Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Squamous Cell Carcinoma of Head and Neck 37Head and Neck Neoplasms 28Prostatic Neoplasms 16Oropharyngeal Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 8Gliosarcoma 8Glioblastoma 8Carcinoma, Squamous Cell 7Brain Neoplasms 7Tongue Neoplasms 6Rectal Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 5Laryngeal Neoplasms 5Astrocytoma 5Papillomavirus Infections 4Neoplasm Metastasis 4Mouth Neoplasms 4Sarcoma 3Neoplasms 3Hypopharyngeal Neoplasms 3Glioma 3Carcinoma 3Breast Neoplasms 3Urinary Bladder Neoplasms 2Thyroid Carcinoma, Anaplastic 2Stomatitis 2Rhabdomyosarcoma 2Radiation Injuries 2

Interventions

fludarabine phosphate 41Peripheral Blood Stem Cell Transplantation 36Cytarabine 32Cyclophosphamide 31Whole-Body Irradiation 30Busulfan 30Tacrolimus 28Mycophenolic Acid 27Methotrexate 18Etoposide 18Cyclosporine 18Antilymphocyte Serum 16Filgrastim 15Melphalan 13Granulocyte Colony-Stimulating Factor 11Idarubicin 10Flow Cytometry 9Clofarabine 9Daunorubicin 8sargramostim 7Radiotherapy 7Mitoxantrone 7Cord Blood Stem Cell Transplantation 7Transplantation 6Thiotepa 6Sirolimus 6merphos 5fludarabine 5aldesleukin 5Vorinostat 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Congenital Abnormalities × Radiotherapy, Intensity-Modulated × Clear all
NCT00544466 2026-02-19

Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

City of Hope Medical Center

Phase 1/2 Active not recruiting
75 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00540995 2023-11-30

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

City of Hope Medical Center

Phase 1/2 Terminated
25 enrolled 9 charts
Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡